Sinemet cr and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sinemet cr (carbidopa; levodopa) and Revlimid (lenalidomide). Common drug interactions include erysipelas among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Sinemet cr and Revlimid. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Sinemet cr?

Sinemet cr has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 2,852 Sinemet cr users. Check the latest studies of Sinemet cr.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 10, 2026

12 people who take Sinemet cr and Revlimid together, and have interactions are studied.

Sinemet cr and Revlimid drug interactions.

What are the common drug interactions of Sinemet Cr and Revlimid, by gender? *:

female:

Erysipelas (bacterial skin infection)
Leukopenia (less number of white blood cells in blood)
Lung disorder (lung disease)
Pneumonia
Pyrexia (fever)
Vomiting

male:

Constipation
Platelet count decreased
Urinary retention (the inability to completely or partially empty the bladder)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fatigue (feeling of tiredness)
Haemoglobin decreased
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Oedema (fluid collection in tissue)
Weight decreased
Full blood count decreased

What are the common drug interactions of Sinemet Cr and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Erysipelas (bacterial skin infection)
Leukopenia (less number of white blood cells in blood)
Lung disorder (lung disease)
Pneumonia
Pyrexia (fever)

60+:

Constipation
Platelet count decreased
Fatigue (feeling of tiredness)
Haemoglobin decreased
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Full blood count decreased
Neuropathy peripheral (surface nerve damage)
Pruritus (severe itching of the skin)
Urinary retention (the inability to completely or partially empty the bladder)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 25.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 25.00%
Stress And Anxiety: 1 person, 8.33%
Pain: 1 person, 8.33%
Oedema Peripheral (superficial swelling): 1 person, 8.33%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 8.33%
Headache (pain in head): 1 person, 8.33%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sinemet cr and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously